Table 2.
Animal no. | Age group at first sampling | Gender | 2017 | 2018 | No total of PCV‐3 positive | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
April | May | June | July | Aug. | Sept. | Oct. | Nov. | Dec. | Jan. | Feb. | March | April | May | ||||
1 | Ju./Sa. | Female | Neg. | Neg. | Neg. | 10 1.3 | Pos. | Neg. | 2/6 | ||||||||
2 | Ju./Sa. | Male | 10 2.39 | 10 2.17 | 10 1.53 | 10 1.1 | 10 1.28 | 5/5 | |||||||||
3 | Ju./Sa. | Male | 10 3 | 10 1.3 | 10 1.3 | 3/3 | |||||||||||
4 | Ju./Sa. | Female | 10 3.06 | Neg. | 1/2 | ||||||||||||
5 | Adult | Male | Neg. | 10 1.3 | 1/2 | ||||||||||||
6 | Ju./Sa. | Female | 10 1.62 /10 2 a | 10 1.3 | 3/3 | ||||||||||||
7 | Adult | Female | Neg. | 10 1.3 | 1/2 | ||||||||||||
8 | Adult | Female | Neg. | Neg. | 0/2 | ||||||||||||
9 | Ju./Sa. | Male | Neg.b | 0/1 | |||||||||||||
10 | Adult | Female | Neg. | Neg. | Neg. | Neg. | Neg. | Neg. | 0/6 | ||||||||
11 | Adult | Female | Neg. | Neg. | 0/2 | ||||||||||||
12 | Ju./Sa. | Female | 10 1.8 | 10 1.22 | Neg. | Neg. | 2/4 | ||||||||||
13 | Ju./Sa. | Female | Neg. | Neg. | Neg. | Neg. | Neg. | 0/5 | |||||||||
14 | Ju./Sa. | Male | 10 3.1 | 10 2,75 | 10 1.56 | 10 1.56 | 4/4 | ||||||||||
15 | Adult | Female | Neg. | Neg. | 0/2 | ||||||||||||
16 | Ju./Sa. | Female | Neg. | Neg. | Neg. | 0/3 | |||||||||||
17 | Ju./Sa. | Male | Neg. | Neg. | 0/2 | ||||||||||||
18 | Ju./Sa. | Female | Pos. | Pos. | 2/2 | ||||||||||||
19 | Ju./Sa. | Male | Neg. | Neg. | 0/2 |
aAnimal longitudinally sampled twice in April, 2017. PCV‐3‐PCR was positive in both samplings. bAnimal longitudinally sampled twice in May, 2017. PCV‐3 PCR was negative in both tested samples.